Denali Therapeutics outlines 2026 milestones including Hunter syndrome launch

Go back to Denali Therapeutics outlines 2026 milestones including Hunter syndrome launch
(NASDAQ: DNLI) Delayed: 24.15 -0.77 (3.09%)
Previous Close $24.92    52 Week High
Open $25.27    52 Week Low
Day High $25.27    P/E N/A 
Day Low $24.00    EPS
Volume 169,566